2026 NPPES data Facial Plastic Surgery Physician NPI 1871904698 D.O.
Verify on CMS →

MATTHEW MORS, D.O.

Facial Plastic Surgery Physician in BOISE, Idaho. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
694
Medicare Part D claims · 244 beneficiaries · Facial Plastic Surgery Physician avg: 428
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$86.29
4 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MATTHEW MORS, D.O. is a Facial Plastic Surgery Physician ([object Object]) practicing in BOISE, Idaho with a Medicare Part D prescribing footprint of 694 claims across 244 beneficiaries — 2% brand-name prescribing . Industry payments of $86.29 across 4 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MATTHEW MORS, D.O. filed 694 Medicare Part D claims in 2023 across BOISE, Idaho. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MATTHEW MORS, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MATTHEW MORS, D.O. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/14/2014

NPI 1871904698

Primary specialty

Facial Plastic Surgery Physician

Niche

607 US NPIs in this specialty

Medicare Part D claims

694 62% vs specialty avg

2023 prescription claims

Specialty avg: 428

Specialty distribution in Idaho

How Facial Plastic Surgery Physician compares to other specialties among Idaho providers

Idaho providers

Facial Plastic Surgery Physician share within Idaho

1. Facial Plastic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Facial Plastic Surgery Physician share within Idaho

Specialty board-certification context

Estimated specialty board-certified rate — Facial Plastic Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Facial Plastic Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Facial Plastic Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Facial Plastic Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW MORS, D.O. is a Facial Plastic Surgery Physician provider practicing in BOISE, Idaho, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1871904698. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MATTHEW MORS, D.O. appears in the CMS NPPES registry as a Facial Plastic Surgery Physician provider holding D.O. credentials at 6052 W STATE ST, BOISE, ID, 83703, with a listed phone of (208) 344-7799. NPI 1871904698 was issued on 05/14/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MORS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 694 prescription claims written by this provider, covering 244 Medicare beneficiaries and totaling roughly $15K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Facial Plastic Surgery Physician is a narrow specialty nationwide, with 607 enrolled providers across 47 states and an average of 428 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6052 W STATE ST
BOISE, ID 83703

Provider Details

NPI 1871904698
Specialty Facial Plastic Surgery Physician
Credentials D.O.
Gender Male
NPI Issued 05/14/2014

Hospital and facility affiliations

Facilities where MATTHEW MORS, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALLIANCE MEDICAL GROUP LLC
BOISE, ID

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW MORS, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$86

Largest payer

Dynavax Technologies Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MATTHEW MORS, D.O. — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 694 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

694
Total Claims
$15K
Total Drug Cost
244
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
955
Total Day Supply
24,075
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$911
Generic Drug Cost
$14K
Opioid Claims
25 (3.6% rate)
Antibiotic Claims
62

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
0.99
Gender Split
55% female / 45% male
Age Distribution
<65: 22, 65-74: 124, 75-84: 84, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ipratropium Bromide
92
Fluticasone Propionate
86
Omeprazole
64
Famotidine
60
Nortriptyline Hcl
55
Azelastine Hcl
47
Mupirocin
38
Sertraline Hcl
29
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
28
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Facial Plastic Surgery Physician Overview

How MATTHEW MORS, D.O. fits within the Facial Plastic Surgery Physician landscape nationally.

607
Facial Plastic Surgery Physician Providers in US
47
States with Facial Plastic Surgery Physician
428
Avg Claims per Provider

MATTHEW MORS, D.O.'s 694 claims are above the specialty average of 428.

Nearby Facial Plastic Surgery Physician Providers in Idaho

Other clinicians with the same primary specialty enrolled in Idaho, drawn from the same CMS NPPES roster as MORS.

Compare Facial Plastic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW MORS, D.O.'s specialty?
MATTHEW MORS, D.O. specializes in Facial Plastic Surgery Physician and practices in BOISE, Idaho. Credentials: D.O..
How much does MATTHEW MORS, D.O. prescribe under Medicare Part D?
In 2023, MATTHEW MORS, D.O. wrote 694 Medicare Part D claims totaling $15K in drug costs for 244 beneficiaries.
Where is MATTHEW MORS, D.O. located?
MATTHEW MORS, D.O. is located at 6052 W STATE ST, BOISE, ID, 83703. Phone: (208) 344-7799.
What is MATTHEW MORS, D.O.'s NPI number?
MATTHEW MORS, D.O.'s National Provider Identifier (NPI) is 1871904698, issued on 05/14/2014.
Does MATTHEW MORS, D.O. prescribe more brand-name or generic drugs?
MATTHEW MORS, D.O.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $911 in brand drug costs.
Does MATTHEW MORS, D.O. prescribe opioids?
Yes, MATTHEW MORS, D.O. had 25 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Facial Plastic Surgery Physician providers are there in the US?
There are 607 Facial Plastic Surgery Physician providers across 47 states in the US. The average Facial Plastic Surgery Physician provider writes 428 Medicare Part D claims per year.
What drugs does MATTHEW MORS, D.O. prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW MORS, D.O.'s most frequently prescribed drugs include Ipratropium Bromide, Fluticasone Propionate, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW MORS, D.O. accept Medicare?
MATTHEW MORS, D.O. appears in CMS Medicare data with 694 Part D claims and 244 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW MORS, D.O.'s credentials?
MATTHEW MORS, D.O.'s NPI is 1871904698 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology